HR Execs on the Move


 
XORTX Therapeutics Inc. is a BioPharmaceutical company focused on developing innovative therapies to treat progressive kidney disease. XORTX has lead programs to develop treatments for progressive kidney disease due to diabetes, diabetic nephropathy, and polycystic kidney disease. Secondary programs focus on developing therapies for health consequences that accompany pre-diabetes, diabetes and cardiovascular disease.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.xortx.com
  • 4000, 421 - 7th Avenue SouthWest
    Calgary, AB CAN T2P 4K9
  • Phone: 403.455.7727

Executives

Name Title Contact Details
Amar Keshri
Chief Financial Officer Profile
James Fairbairn
Chief Financial Officer Profile

Similar Companies

Fisher Wallace Laboratories

The Fisher Wallace Stimulator® is a wearable neurostimulation device cleared by the FDA to treat depression, anxiety and insomnia. During each 20-minute treatment session, the device gently stimulates the brain to produce serotonin and other neurochemi...

Retia Medical

Retia Medical provides accurate, simple, low-cost cardiac output monitoring.

The Harvard Drug Group

The Harvard Drug Group is a Livonia, MI-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Sequella

Sequella is a Rockville, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Arro Corporation

Arro Corporation is a Chicago, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.